Skip to main content

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overviewAll 13F holders of XENEFull Q2 2026 holdings

Shares (Q2 2026)
370,208
Value
$22.3M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of XENE by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026370,208$22.3M0.1%00.0%UnchangedHolders
Q1 2026370,208$21.5M0.1%00.0%UnchangedHolders
Q4 2025370,208$16.6M0.1%00.0%UnchangedHolders
Q3 2025370,208$14.9M0.1%00.0%UnchangedHolders
Q2 2025370,208$11.6M0.1%+22,800+6.6%AddedHolders
Q1 2025347,408$11.7M0.1%−646,271−65.0%ReducedHolders
Q4 2024993,679$39.0M0.4%00.0%UnchangedHolders
Q3 2024993,679$39.1M0.4%00.0%UnchangedHolders
Q2 2024993,679$38.7M0.5%00.0%UnchangedHolders
Q1 2024993,679$42.8M0.5%00.0%UnchangedHolders
Q4 2023993,679$45.8M0.5%+242,040+32.2%AddedHolders
Q3 2023751,639$25.7M0.1%00.0%UnchangedHolders
Q2 2023751,639$28.9M0.2%00.0%UnchangedHolders
Q1 2023751,639$26.9M0.1%00.0%UnchangedHolders
Q4 2022751,639$29.6M0.2%00.0%UnchangedHolders
Q3 2022751,639$27.1M0.2%00.0%UnchangedHolders
Q2 2022751,639$22.9M0.1%00.0%UnchangedHolders
Q1 2022751,639$23.0M0.1%00.0%UnchangedHolders
Q4 2021751,639$23.5M0.1%00.0%UnchangedHolders
Q3 2021751,639$11.5M0.1%00.0%UnchangedHolders
Q2 2021751,639$14.0M0.1%00.0%UnchangedHolders
Q1 2021751,639$13.5M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.